Haussier
Johnson & Johnson's stock rises 1.1% after strong Q2 earnings report
Ce briefing n’est pas encore disponible dans cette langue — version anglaise affichée.
Johnson & Johnson's stock increased by 1.1% following the release of its Q2 2026 earnings report, which exceeded analysts' expectations. The company reported earnings per share (EPS) of $2.90, surpassing the consensus estimate of $2.84, and revenue of $25.31 billion, exceeding the anticipated $25.06 billion.
Points clés
- Q2 2026 earnings report shows strong performance, with EPS of $2.90 and revenue of $25.31 billion.
- D.A. Davidson & Co. reduced its stake in Johnson & Johnson by 7.1%, selling 50,822 shares.
- Boston Trust Walden Corp decreased its holdings in Johnson & Johnson by 11.2%, selling 74,565 shares.
Sources
Généré par IA à partir de sources d'actualités publiques. Ceci n'est pas un conseil financier.
